AI Health Startups
Company formation, product launches, acquisitions and IPO news from healthcare AI startups, with Turkey and global market context.
The operating model for safe healthcare AI in 2026
A board-ready framework for governing healthcare AI with clinical ownership, local validation, incident review and post-deployment monitoring.
Cardiology AI: from ECG signal to longitudinal risk intelligence
Cardiology AI has value when it links signals to defined clinical pathways, not when it produces isolated risk scores without follow-up capacity.
Pathology AI and the quiet industrialisation of diagnosis
Pathology AI is a digital-lab transformation story: algorithms matter only after slide quality, scanner consistency, routing and report integration are controlled.
Oncology AI and the economics of precision care
Oncology AI is valuable when it makes precision care usable and access-aware: molecular interpretation, trial matching and tumour-board synthesis must change real decisions.
Company and startup news
AI drug discovery after AlphaFold: what changes, what does not
AlphaFold 3 strengthens AI drug discovery by improving structural and interaction hypotheses; it does not replace experimental validation or clinical trials.
Genomics, polygenic risk and the next frontier of clinical AI
Genomic AI can support prevention only when risk scores are ancestry-aware, probabilistic and connected to counselling and follow-up pathways.
The data governance layer behind trustworthy medical AI
The data governance layer behind trustworthy medical AI with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Hospital procurement for healthcare AI: a playbook for executives
Hospital procurement for healthcare AI: a playbook for executives with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
The EU AI Act for physicians and hospital leaders
The EU AI Act for physicians and hospital leaders with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Healthcare AI and privacy: from consent forms to technical controls
Healthcare AI and privacy: from consent forms to technical controls with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Turkey’s healthcare AI opportunity: build, buy or regulate?
Turkey’s healthcare AI opportunity: build, buy or regulate? with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Physician burnout and AI: productivity tool or another inbox?
Physician burnout and AI: productivity tool or another inbox? with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Medical education in the age of clinical copilots
Medical education in the age of clinical copilots with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
The Middle East health-AI race: capital, data and clinical credibility
The Middle East health-AI race: capital, data and clinical credibility with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T…
Patient-facing symptom checkers need a new safety architecture
Patient-facing symptom checkers need a new safety architecture with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Nursing, allied health and the overlooked healthcare AI workforce
Nursing, allied health and the overlooked healthcare AI workforce with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Remote patient monitoring with AI: beyond dashboards
Remote patient monitoring with AI: beyond dashboards with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Why AI-enabled medical devices are becoming a board-level issue
AI-enabled medical devices are board-level issues because they affect clinical risk, contracts, data governance, update policy and post-market monitoring, not only clinical…
Diabetes AI and continuous glucose data: from pattern spotting to clinical action
Diabetes AI and continuous glucose data: from pattern spotting to clinical action with source-led analysis, clinical governance, Turkey/regional context and a pre-publication…
Mental health AI: access, evidence and the line between coach and clinician
Mental health AI: access, evidence and the line between coach and clinician with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T…
Emergency triage AI and the price of being wrong fast
Emergency triage AI and the price of being wrong fast with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Sepsis early-warning systems: the hard lesson in clinical AI deployment
Sepsis early-warning systems: the hard lesson in clinical AI deployment with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T…
Surgical AI and robotics: augmentation before autonomy
Surgical AI and robotics: augmentation before autonomy with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Rare disease diagnosis and AI: the value of pattern memory
Rare disease diagnosis and AI: the value of pattern memory with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Model drift in medicine: the risk that arrives after launch
Model drift in medicine: the risk that arrives after launch with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Pharma strategy in the medical AI era
Pharma strategy in the medical AI era with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Pharma’s AI story moves from discovery hype to portfolio discipline
Pharma’s AI story moves from discovery hype to portfolio discipline with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Healthcare AI startups face a tougher evidence market
Healthcare AI startups face a tougher evidence market with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Primary sources tracked by DoktorClub editors
Trusted sources the DoktorClub editorial team monitors for this cluster: